Characteristics of cirrhosis
| Cirrhosis (n = 7) | No cirrhosis (n = 4) | p Value | |
|---|---|---|---|
| MPA, main pulmonary artery; SVEDP, systemic ventricular end-diastolic pressure. | |||
| Values are mean (SD, range). | |||
| Fontan duration (years) | 15.9 (5.4, 12.2–26.4) | 11.6 (4.8, 6.9–17.9) | 0.286 |
| Hepatic vein wedge pressure (mm Hg) | 17.9 (6.4, 10–30) | 11.7 (1.5, 10–13) | 0.063 |
| Hepatic vein pressure (mm Hg) | 17.7 (6.3, 10–30) | 11 (1.7, 9–12) | 0.049 |
| Fontan pressure (mm Hg) | 16.4 (6.1, 9–28) | 11.3 (2, 9–13) | 0.135 |
| MPA pressure (mm Hg) | 17.4 (5.8, 11–28) | 11.3 (2, 9–13) | 0.136 |
| SVEDP (mm Hg) | 10 (5.1, 3–17) | 6.3 (1.5, 5–8) | 0.230 |
| Ejection fraction (%) | 46.3 (4.8, 38–50) | 45 (5, 40–50) | 0.680 |
| Aortic saturation | 93.7 (4.6, 88–98) | 97 (4.4, 92–100) | 0.209 |
| Hepatic vein wedge saturation | 58.7 (13.7, 38–75) | 60 (8.7, 54–70) | 0.796 |
| Hepatic vein saturation | 48 (22.2, 14–76) | 54 (3.8, 50–57) | 0.297 |
| Gastro-oesophageal varices | 4/7 | 0/4 | 0.200 |
| Zonal enhancement | 1/7 | 3/4 | 0.033 |
| Hypervascular nodules | 2/7 | 0/4 | 1.000 |
| Reticular enhancement | 6/7 | 2/4 | 0.183 |